Malaria – ein internistischer Notfall

Schlüsselwörter

Malaria - P. falciparum - P. knowlesi - Artemisinin-Kombinationspräparate

Keywords

Malaria - P. falciparum - P. knowlsei - artemisinin combination treatment

• Literatur

• 1 Alving AS, Johnson CF, Tarlov AR et al. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull World Health Organ 1960; 22: 621-631
• 2 Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis 2004; 39: 1336-1345
• 3 Baird JK. Resistance to therapies for infection by plasmodium vivax. Clin Microbiol Rev 2009; 22: 508-534
• 4 Bassat Q. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria. PLoS Negl Trop Dis 2011; 5: e1325
• 5 Centers for Disease Control and Prevention, USA. Choosing a drug to prevent malaria. http://www.cdc.gov/malaria/travelers/drugs.html letzter Zugriff: 20.9.2012
• 6 Daneshvar C, Davis TM, Cox-Singh J et al. Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis 2009; 49: 852-860
• 7 Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG). Empfehlungen zur Malariavorbeugung. http://www.dtg.org/uploads/media/Malaria_2012_01.pdf Letzter Zugriff: 20.9.2012
• 8 Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG). Leitlinien Malaria. 2011 www.dtg.org
• 9 EMA. Eurartesim Product Information. 2011 www.ema.europa.eu/docs/de_DE/document_library/ EPAR_Product_Information/human/001199/WC500118113-2.pdf
• 10 Galappaththy GNL, Omari AAA, Tharyan P. Primaquine for preventing relapses in people with Plasmodium vivax malaria. Cochrane Database of Systematic Reviews 2007; 1 CD004389
• 11 Guerra CA, Gikandi PW, Tatem AJ et al. The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med 2008; 5: e38
• 12 Guerra CA, Howes RE, Patil AP et al. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 2010; 4: e774
• 13 Hay SI, Okiro EA, Gething PW et al. Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med 2010; 7: e1000290
• 14 Hill DR, Baird JK, Parise ME et al. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 2006; 75: 402-415
• 15 Holding PA, Stevenson J, Peshu N et al. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg 1999; 93: 529-534
• 16 Jelinek T, Nothdurft HD, Löscher T. Malaria in nonimmune travelers: A synopsis of history, symptoms, and treatment in 160 Patients. J Travel Med 1994; 1: 199-202
• 17 Jelinek T, Schulte C, Behrens R et al. Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis 2002; 34: 572-576
• 18 Miranda IB, Weber C, Fleischmann E et al. Validity of malaria diagnosis in nonimmune travelers in endemic areas. J Travel Med 2008; 15: 426-31
• 19 Mohanty S, Mishra SK, Patnaik R et al. Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial. Clin Infect Dis 2011; 53: 349-355
• 20 Mueller I, Galinski MR, Baird JK et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 2009; 9: 555-566
• 21 Namutangula B, Ndeezi G, Byarugaba JS et al. Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial. Malar J 2007; 6: 138
• 22 Okoromah CA, Afolabi BB, Wall EC. Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria. Cochrane Database Syst Rev 2011; 13 CD004615
• 23 Robert Koch Institut. Epidemiologisches Bulletin Nr. 41, 2011 – Reiseassoziierte Infektionskrankheiten. 2010 http://edoc.rki.de/documents/rki_fv/re5VVlWgMxWc/PDF/29YxYwLb1B3H6.pdf Letzter Zugriff: 20.9.2012
• 24 Robert Koch-Institut. SurvStat. http://www3.rki.de/SurvStat Datenstand: 15.08.2012
• 25 Roze E, Thiebaut MM, Mazevet D et al. Neurologic sequelae after severe falciparum malaria in adult travelers. Eur Neurol 2001; 46: 192-197
• 26 Sinclair D, Donegan S, Isba R et al. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev 2012; 6 CD005967
• 27 Singh B, Kim Sung L, Matusop A et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 2004; 363: 1017-1024
• 28 Sutherland CJ, Tanomsing N, Nolder D et al. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis 2010; 201: 1544-1550
• 29 Tan KR, Magill AJ, Parise ME et al. Centers for Disease Control and Prevention. Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg 2011; 84: 517-31
• 30 Wilby KJ, Lau TT, Gilchrist SE et al. Mosquirix (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malaria. Ann Pharmacother 2012; 46: 384-93
• 31 WHO, World Health Organization. Guidelines for the treatment of malaria. 2010 2nd. edition. http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf letzter Zugriff 20.9.2012
• 32 WHO. Global Malaria Programme. Good practices for selecting and procuring rapid diagnostic tests for malaria. Malta.: WHO; 2011
• 33 WHO. Malaria factsheet No. 94. www.who.int/mediacentre/factsheets/fs094/en/
• 34 World Health Organization. Global plan for artemisinin resistance containment (GPARC). Global Partnership to Roll Back Malaria & World Health Organization, Geneva, 2011
• 35 World Health Organization. Global report on antimalarial drug efficacy and drug resistance: 2000-2010. Geneva: 2011